Daniel Harari
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cytokine Signaling Pathways and Interactions
- Immunology top 10%
- interferon and immune responses
Papers in
- Oncology 13
- Cytokine Signaling Pathways and Interactions 11
- HER2/EGFR in Cancer Research 3
-
- Glycosylation and Glycoproteins Research 2
- Heat shock proteins research 2
- Co-authors
- Y Yarden (1 shared paper)Gideon Schreiber (14 shared papers)Yosef Yarden (6 shared papers)Jan E. Romano (1 shared paper)Maya Shelly (1 shared paper)Eldad Tzahar (1 shared paper)Doron Levin (2 shared papers)Ami Citri (3 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Molecular and Cellular Biology (3 papers)Oncogene (2 papers)PLoS ONE (2 papers)Cytokine (2 papers)
- Partner nations
- IsraelGermanySwitzerland
In The Last Decade
Daniel Harari
30 papers receiving 2.0k citations
Daniel Harari's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 667
- Immunology 382
- Infectious Diseases 312
- Radiology, Nuclear Medicine and Imaging 315
- Molecular Biology 1.0k
Countries citing papers authored by Daniel Harari
This map shows the geographic impact of Daniel Harari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Harari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Harari more than expected).
Fields of papers citing papers by Daniel Harari
This network shows the impact of papers produced by Daniel Harari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Harari. The network helps show where Daniel Harari may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Harari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 486 | |
| 2 | 1999 | 266 | |
| 3 | SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution Hit paper breakdown → | 2021 | 236 |
| 4 | 2006 | 199 | |
| 5 | 2002 | 130 | |
| 6 | 2021 | 87 | |
| 7 | 2011 | 86 | |
| 8 | 2004 | 85 | |
| 9 | 2009 | 83 | |
| 10 | 2002 | 76 | |
| 11 | 2014 | 59 | |
| 12 | 2012 | 56 | |
| 13 | 2006 | 51 | |
| 14 | 2006 | 48 | |
| 15 | 2014 | 32 | |
| 16 | Coronavirus: Economic impact | 2021 | 21 |
| 17 | 1997 | 20 | |
| 18 | 2022 | 11 | |
| 19 | 2020 | 9 | |
| 20 | 2015 | 8 |
About Daniel Harari
Daniel Harari is a scholar working on Oncology, Molecular Biology, Immunology, Infectious Diseases and Genetics, having authored 35 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (11 papers), interferon and immune responses (10 papers), SARS-CoV-2 and COVID-19 Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Systemic Lupus Erythematosus Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Heat shock proteins research (2 papers). The work is most often cited by research in Oncology (667 citations), Immunology (382 citations), Infectious Diseases (312 citations), Radiology, Nuclear Medicine and Imaging (315 citations) and Molecular Biology (1.0k citations). Daniel Harari has collaborated with scholars based in Israel, Germany and Switzerland. Frequent co-authors include Y Yarden, Gideon Schreiber, Yosef Yarden, Jan E. Romano, Maya Shelly, Eldad Tzahar, Doron Levin, Ami Citri, Sara Lavi and Maya Shemesh. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Oncogene, PLoS ONE and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.